Predominance of Lactobacillus spp. among Patients Who Do Not Acquire Multidrug-Resistant Organisms

Clinical Infectious Diseases

Volumn 63, Issue 7, 2016, Pages 937-943

  Araos, Rafael ^a   Tai, Albert K ^b   Snyder, Graham M ^c   Blaser, Martin J ^d   D'Agata, Erika M C ^e  

^a UNIVERSIDAD DEL DESARROLLO   (Chile)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e BROWN UNIVERSITY   (United States)

Author keywords

acquisition; hospital; microbiome; multidrug resistant organisms; risk factors

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM; CEFAZOLIN; DNA; RNA 16S; VANCOMYCIN;

ACTINOBACTERIA; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; BACTEROIDES; BACTEROIDETES; BLAUTIA; CITROBACTER FREUNDII; CLINICAL ARTICLE; CLOSTRIDIA; COMMUNITY STRUCTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA EXTRACTION; ENTEROCOCCUS; ESCHERICHIA; ESCHERICHIA COLI; FEMALE; FIRMICUTES; FOLLOW UP; GENE SEQUENCE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL DIVERSITY; MULTIDRUG RESISTANT ORGANISM; NEXT GENERATION SEQUENCING; NONHUMAN; ORGANISMS; PARABACTEROIDES; PRIORITY JOURNAL; PROTEOBACTERIA; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; RUMINOCOCCUS; BACTERIAL INFECTION; CROSS INFECTION; DRUG EFFECTS; GENETICS; HOSPITALIZATION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MICROFLORA; MULTIDRUG RESISTANCE; PROSPECTIVE STUDY; RECTUM; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALIZATION; HUMANS; LACTOBACILLUS; MICROBIOTA; PROSPECTIVE STUDIES; RECTUM; RISK FACTORS;

EID: 84990888754     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw426     Document Type: Article

References (40)

1. Laxminarayan R, Duse A,Wattal C, et al. Antibiotic resistance\-The need for global solutions. Lancet Infect Dis 2013; 13:1057-98.
2. Howell WL; World Economic Forum Risk Response Network. Global risks 2013. Cologny, Switzerland: World Economic Forum, 2013.
3. Spellberg B, Bartlett J, Gilbert D. The future of antibiotics and resistance. N Engl J Med 2013; 368:299-302.
4. Tosh PK, McDonald LC. Infection control in the multidrug-resistant era: tending the human microbiome. Clin Infect Dis 2012; 54:707-13.
5. Buffie CG, Pamer EG. Microbiota-mediated colonization resistance against intestinal pathogens. Nat Rev Immunol 2013; 13:790-801.
6. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci 2011; 108:4554-61.
7. Britton RA, Young VB. Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology 2014; 146:1547-53.
8. Taur Y, Pamer EG. The intestinal microbiota and susceptibility to infection in immunocompromised patients. Curr Opin Infect Dis 2013; 26:332-7.
9. Ubeda C, Bucci V, Caballero S, et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 2013; 81:965-73.
10. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42:377-81.
11. Snyder GM, D'Agata EMC. Diagnostic accuracy of surveillance cultures to detect gastrointestinal colonization with multidrug-resistant gram-negative bacteria. Am J Infect Control 2012; 40:474-6.
12. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486:222-7.
13. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Supplement M100-S21, 2011.
14. Caporaso JG, Lauber CL, Walters WA, et al. Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 2012; 6:1621-4.
15. Caporaso JG, Kuczynski J, Stombaugh J, et al. QIIME allows analysis of highthroughput community sequencing data. Nat Methods 2010; 7:335-6.
16. Edgar RC. Search and clustering orders of magnitude faster than BLAST. Bioinformatics 2010; 26:2460-1.
17. Caporaso JG, Bittinger K, Bushman FD, DeSantis TZ, Andersen GL, Knight R. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics 2010; 26:266-7.
18. McDonald D, Price MN, Goodrich J, et al. An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea. ISME J 2012; 6:610-8.
19. Lozupone C, Knight R. UniFrac: a new phylogenetic method for comparing microbial communities. Appl Environ Microbiol 2005; 71:8228-35.
20. Vázquez-Baeza Y, Pirrung M, Gonzalez A, Knight R. EMPeror: a tool for visualizing high-throughput microbial community data. GigaScience 2013; 2:16.
21. Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:R60.
22. Huttenhower C, Gevers D, Knight R, et al. Structure, function and diversity of the healthy human microbiome. Nature 2012; 486:207-14.
23. O'Sullivan O, Coakley M, Lakshminarayanan B, et al. Alterations in intestinal microbiota of elderly Irish subjects post-antibiotic therapy. J Antimicrob Chemother 2013; 68:214-21.
24. Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6:e280.
25. Chang JY, Antonopoulos DA, Kalra A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis 2008; 197:435-8.
26. Taur Y, Xavier JB, Lipuma L, et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2012; 55:905-14.
27. Taur Y, Jenq RR, Perales M-A, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood 2014; 124:1174-82.
28. Jenq RR, Taur Y, Devlin SM, et al. Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biol Blood Marrow Transplant 2015; 21:1373-83.
29. de Sablet T, Chassard C, Bernalier-Donadille A, Vareille M, Gobert AP, Martin C. Human microbiota-secreted factors inhibit Shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 2009; 77:783-90.
30. Buffie CG, Bucci V, Stein RR, et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2014; 517:205-8.
31. Patel R, DuPont HL. New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis 2015; 60:S108-21.
32. Wullt M, Hagslätt M-LJ, Odenholt I. Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis 2003; 35:365-7.
33. Abujamel T, Cadnum JL, Jury LA, et al. Defining the vulnerable period for reestablishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole. PLoS One 2013; 8:e76269.
34. Kwon JH, Bommarito KM, Reske KA, et al. Randomized controlled trial to determine the impact of probiotic administration on colonization with multidrug-resistant organisms in critically ill patients. Infect Control Hosp Epidemiol 2015; 36:1451-4.
35. Lievin-Le Moal V, Servin AL. Anti-infective activities of Lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agents. Clin Microbiol Rev 2014; 27:167-99.
36. Agata EMD, Gautam S, Green WK, Tang Y-W. High rate of false-negative results of the rectal swab culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci. Clin Infect Dis 2002; 34:167-72.
37. Rossi F, Diaz L,Wollam A, et al. Transferable vancomycin resistance in a community-associated MRSA lineage. N Engl J Med 2014; 370:1524-31.
38. Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 2013; 13:785-96.
39. Halpin AL, McDonald LC. The dawning of microbiome remediation for addressing antibiotic resistance. Clin Infect Dis 2016; 62:1487-8.
40. Crum-Cianflone NF, Sullivan E, Ballon-Landa G. Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization. J Clin Microbiol 2015; 53:1986-9.